Literature DB >> 300495

T-cell regulation of immunoglobulin synthesis and proliferation in pokeweed (Pa-1)-stimulated human lymphocyte cultures.

G Janossy, E Gomez de la Concha, A Luquetti, M J Snajdr, M J Waxdal, T A Platts-Mills.   

Abstract

In pokeweed (Pa-1)-stimulated human lymphocyte cultures, T cells are essential for the survival, proliferation, plasma-cell development, and high-rate Ig secretion of B cells. Their effects are T-cell-specific in the sense that B-cell stimulation does not take place in the absence of T cells even when fibroblasts or monocytes are provided. The experimental system is the most effective model for activation of human B lymphocytes so far described. Plasmablast development requires approximately 7 days in culture. In T + B-cell cultures established at 1 X 10(6)/ml (1 X 10(4)/mm2) initial cell density, plasma cells can secrete, on the average, as much as 40-70 pg IgM or IgG per cell per day. When the initial T-cell density is increased well above 1.0 X 10(6)/ml, a T-cell-mediated depression of Ig synthesis becomes predominant. Thus, in the pokeweed model T-cell effects represent a balance of helper and suppressor influences. The study also shows that B cells are heterogeneous. A non-adherent IgG-committed (smIg-?) TONSIL B-cell population seems to be less susceptible to T suppressor effects than normal tonsil B cells. This subset proliferates particularly well and synthesizes large quantities of IgG in the presence of large initial proportions of T cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300495     DOI: 10.1111/j.1365-3083.1977.tb00326.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  35 in total

1.  Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

2.  Functional studies on T cells in adult human bone marrow.

Authors:  G C De Gast; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

3.  Expression of low-density lipoprotein receptors in peripheral blood and tonsil B lymphocytes.

Authors:  J B De Sanctis; I Blanca; H Rivera; N E Bianco
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

4.  The production of a soluble human T-lymphocyte derived factor which substitutes for helper T lymphocytes in the in vitro production of immunoglobulin.

Authors:  R H Stevens; C J Thiele; A Saxon
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

5.  Functional assessment of a B cell defect in patients with selective IgA deficiency.

Authors:  J T Cassidy; G Oldham; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

6.  Immunoglobulin systems of human tonsils. I. Control subjects of various ages: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations.

Authors:  P Brandtzaeg; L Surjan; P Berdal
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

7.  IgA synthesis by peripheral blood mononuclear cells from normal and selectively IgA deficient subjects.

Authors:  M A King; J V Wells; D S Nelson
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

8.  Glucocorticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes. III. Common variable immunodeficiency.

Authors:  D A Cooper; P Hansen; M Duckett; J B Ziegler; R Penny
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

9.  Formalin-treated bacteria as selective B cell mitogens in the study of lymphocytes from patients with hypogammaglobulinaemia.

Authors:  G Banck; A Forsgren
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

10.  Chronic lymphocytic leukemia cells lack the 185,000-dalton macromolecular insoluble cold globulin present on normal B lymphocytes.

Authors:  M A Simmonds; G Sobczak; S P Hauptman
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.